For citations:
Ambalov Yu.M., Kovalenko A.P., Pshenetskaya O.A., Ryazanova O.A. Combined use of direct antiviral drugs - paritrapevir, ritonavir, ombitasvir and dasabuvir in the treatment of patients with HCV-deterministic compensated cirrhosis in real clinical practice. Medical Herald of the South of Russia. 2018;9(2):88-91. (In Russ.) https://doi.org/10.21886/2219-8075-2018-9-2-88-91
Email this article 